Study to Treat Relapsed Follicular Non-Hodgkin's Lymphoma With Radiation and Bexxar
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Follicular Lymphoma
Related studies linked through entity extraction aliases.
Dietary Intervention in Follicular Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Safety & Efficacy Study of AT-101 in Combination w/ Rituximab in Previously Untreated Grade I-II Follicular Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Comparison of High-Dose Chemotherapy + Rituximab and CHOP + Rituximab in High-Risk Follicular Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE3
A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Efficacy of Fludarabine and Cyclophosphamide + Rituximab
- Status
- COMPLETED
- Phase
- PHASE2
Phase 3 Study of Zevalin Following R-CVP in Previously Untreated Patients With Follicular Non Hodgkin's Lymphoma (NHL)
- Status
- TERMINATED
- Phase
- PHASE3
Immunochemotherapy, in Vivo Purging, PBSC Mobilization and Autotransplant in Relapsed or Refractory Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Safety and Efficacy Study of Single-agent AT-101 in Patients With Relapsed or Refractory B-cell Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Fludarabine, Mitoxantrone and Rituximab in Relapsed or Primary Failing Advanced Follicular Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Primary Rituximab and Maintenance
- Status
- COMPLETED
- Phase
- PHASE3
Randomized Study for Patients With Follicular Lymphoma Needing Treatment
- Status
- COMPLETED
- Phase
- PHASE3
A Phase 2 Study of Velcade™ in Subjects With Relapsed or Refractory Follicular B-Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Radiotherapy Versus Radiotherapy Plus Chemotherapy in Early Stage Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202)
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
VELCADE® (Bortezomib) With Rituximab in Subjects With Relapsed or Refractory Indolent B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Combination Antibody Therapy for Relapsed Lymphoma and Chronic Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype
- Status
- COMPLETED
- Phase
- PHASE1
Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines
- Status
- COMPLETED
- Phase
- PHASE1